Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prof David Beard was the keynote speaker at a recent Surgical Trials Workshop in Ho Chi Minh City, Vietnam, contributing to improved treatment quality and greater international integration in healthcare and medical science.

Prof David Beard with some of the doctors on the Surgical Trials Course in Vietnam
Prof David Beard with some of the doctors on the Surgical Trials Course in Vietnam

More than 40 doctors, surgeons, and researchers from leading hospitals across Ho Chi Minh City gathered for the “Surgical Trials Workshop”. The event, held in collaboration with the Sydney Vietnam Institute (SVI), Gia Dinh People’s Hospital, and the Ho Chi Minh City Department of Health, represented a significant milestone in strengthening Vietnam’s clinical research capacity.

Prof David Beard led the workshop which featured content adapted from the 3-day BOASTiC (Bristol, Oxford and Aberdeen Surgical Trials Course), which David co-directs and has successfully run in the UK for 12 years.

In his talks, David explored the distinct nature of surgical trials compared to other medical research fields, highlighting the unique challenges and ethical considerations involved. He provided an in-depth overview of the entire clinical trial process—from defining research questions and selecting outcome measures to managing risk, ensuring ethical integrity, and disseminating findings. Drawing on his experience from ten international surgical trials, David shared valuable practical insights and lessons to help Vietnamese researchers and surgeons develop feasible, context-appropriate research initiatives.

David said: ‘We continue our journey to advance surgical evaluation in Vietnam, working closely with our valued colleagues. This workshop in Ho Chi Minh City built upon the success of our previous workshop held in Hanoi in 2024 and was very well received. We look forward to fostering new partnerships and exploring collaborative opportunities in a range of surgical interventions in the near future.’

Similar stories

NDORMS researchers win prestigious national leadership prizes

Professor of Orthopaedic Trauma Matthew Costa and NIHR Doctoral Research Fellow Rachel Kuo were announced among the winners of the NIHR20 Research Leaders Prizes in recognition of their outstanding contribution to health and care research.

From Paraguay to Oxford: Mariela’s experience of the Trueta Bursary

Mariela Ortiz, a pharmacist from Paraguay received a Trueta Bursary to attend the Botnar Institute's Summer School in Real World Evidence this June.

Arthritis origins may begin before birth, study finds

Researchers at the Kennedy Institute have discovered that some joints may be more susceptible to inflammatory arthritis before birth, offering new insight into why rheumatoid arthritis attacks particular joints while sparing others.

NDORMS student wins national research prize

A medical student at NDORMS has gained a top prize in the prestigious 2026 Falk Foundation/Guts UK Charity national awards. Sara Lyden won the Medical Student Prize for her research project, ‘Integrating histo-molecular patient profiles with patient reported symptoms and quality of life measures in ulcerative colitis.’

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

The first patient in the UK has been recruited to a clinical trial investigating how a new drug affects liver inflammation and scarring in people with psoriatic disease using a new non-invasive MRI scanning technique.

NDORMS team wins Award for Excellence for transforming ulcerative colitis care

The Sagittarius Team, a pioneering partnership between the University of Oxford and Oxford University Hospitals (OUH) has been recognised with the OUH Award for Excellence 2026 for transforming care for people experiencing a relapse of ulcerative colitis while advancing translational research.